Urologix, Inc. (ULGX)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 14, 2025
Urologix Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | 2009 - 2005 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '15 Mar 31, 2015 | Jun '14 Jun 30, 2014 | Jun '13 Jun 30, 2013 | Jun '12 Jun 30, 2012 | Jun '11 Jun 30, 2011 | Jun '10 Jun 30, 2010 | 2009 - 2005 |
| Revenue | 12 | 14.01 | 16.48 | 17.03 | 12.57 | 14.77 | Upgrade
|
| Revenue Growth (YoY) | -19.41% | -15.00% | -3.19% | 35.45% | -14.89% | 15.25% | Upgrade
|
| Cost of Revenue | 6.34 | 8.12 | 8.13 | 8.65 | 6.03 | 6.57 | Upgrade
|
| Gross Profit | 5.66 | 5.9 | 8.35 | 8.38 | 6.54 | 8.2 | Upgrade
|
| Selling, General & Admin | 5.14 | 8.15 | 10.23 | 9.97 | 7.9 | 8.6 | Upgrade
|
| Research & Development | 1.31 | 1.63 | 2.27 | 2.19 | 2.24 | 1.83 | Upgrade
|
| Operating Expenses | 6.53 | 9.87 | 12.61 | 12.25 | 10.16 | 10.46 | Upgrade
|
| Operating Income | -0.87 | -3.97 | -4.26 | -3.87 | -3.62 | -2.26 | Upgrade
|
| Interest Expense | -0.77 | -0.69 | -0.56 | -0.48 | - | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0 | -0.01 | -0.01 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -1.66 | -4.67 | -4.82 | -4.36 | -3.62 | -2.26 | Upgrade
|
| Merger & Restructuring Charges | -0.03 | -0.03 | - | -0.29 | -0.1 | - | Upgrade
|
| Impairment of Goodwill | -3.04 | -3.04 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.32 | - | - | - | Upgrade
|
| Asset Writedown | - | - | -0.43 | - | - | - | Upgrade
|
| Other Unusual Items | - | 0.11 | 0.65 | 0.01 | - | - | Upgrade
|
| Pretax Income | -4.72 | -7.62 | -4.28 | -4.64 | -3.73 | -2.26 | Upgrade
|
| Income Tax Expense | -0.05 | -0.02 | 0.01 | 0.06 | 0.01 | -0.09 | Upgrade
|
| Net Income | -4.67 | -7.61 | -4.29 | -4.7 | -3.73 | -2.17 | Upgrade
|
| Net Income to Common | -4.67 | -7.61 | -4.29 | -4.7 | -3.73 | -2.17 | Upgrade
|
| Shares Outstanding (Basic) | 22 | 21 | 21 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 22 | 21 | 21 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 2.26% | 2.49% | 40.45% | 1.27% | 0.33% | 0.27% | Upgrade
|
| EPS (Basic) | -0.22 | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 | Upgrade
|
| EPS (Diluted) | -0.22 | -0.36 | -0.21 | -0.32 | -0.26 | -0.15 | Upgrade
|
| Free Cash Flow | -0.28 | -1.56 | -2.04 | -0.77 | -2.64 | -1.34 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.07 | -0.10 | -0.05 | -0.18 | -0.09 | Upgrade
|
| Gross Margin | 47.13% | 42.08% | 50.66% | 49.23% | 52.03% | 55.53% | Upgrade
|
| Operating Margin | -7.28% | -28.35% | -25.82% | -22.72% | -28.82% | -15.28% | Upgrade
|
| Profit Margin | -38.90% | -54.30% | -26.04% | -27.57% | -29.70% | -14.68% | Upgrade
|
| Free Cash Flow Margin | -2.29% | -11.15% | -12.36% | -4.52% | -21.02% | -9.04% | Upgrade
|
| EBITDA | -0.37 | -3.39 | -3.58 | -3.17 | -3.06 | -1.46 | Upgrade
|
| EBITDA Margin | -3.11% | -24.16% | -21.73% | -18.64% | -24.33% | -9.91% | Upgrade
|
| D&A For EBITDA | 0.5 | 0.59 | 0.67 | 0.7 | 0.57 | 0.79 | Upgrade
|
| EBIT | -0.87 | -3.97 | -4.26 | -3.87 | -3.62 | -2.26 | Upgrade
|
| EBIT Margin | -7.28% | -28.35% | -25.82% | -22.72% | -28.82% | -15.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.